Navigation Links
Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
Date:4/9/2009

EXTON, Pa., April 9 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its third quarter ended March 31, 2009 at 7:30 A.M. Eastern Time on Wednesday, April 22, 2009.

Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Wednesday, April 22, 2009 at 9:00 A.M. Eastern Time.

To participate in the teleconference call, dial 1-612-234-9959. The teleconference call will also be available for replay starting Wednesday, April 22, 2009 at 11:00 A.M. Eastern Time through Wednesday, April 29, 2009 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 995293.

Individuals interested in listening to the teleconference may also do so over the Internet at www.kenseynash.com. To listen to the live teleconference call, please go to the www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the www.kenseynash.com website and may be accessed following the teleconference.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kensey Nash Announces 600,000 Share Stock Repurchase Program
2. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
3. Kensey Nash Announces Appointment of Chief Financial Officer
4. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
5. Kensey Nash Announces Director Resignation
6. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
7. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
8. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
9. Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
10. Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
11. Kensey Nash to Participate in the Friedman Billings Ramsey 12th Annual Spring Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... for clear braces. People who want straight teeth without the extensive time commitment ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible ...
(Date:3/27/2017)... ... March 27, 2017 , ... This is the ... popHealth Community in 2014. It is the culmination of collaborative efforts by ... Project Group. OSEHRA Organizational Member Zato Health co-funded the ONC certification and provided ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first name ... the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to products ... as ANSI, ISO and proven test methods used in the field of Vision ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... N.H. , March 27, 2017  iCAD ... analysis, workflow solutions and radiation therapy for the ... that PowerLook® Tomo Detection received Premarket Approval (PMA) ... PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer ... and is the latest innovation available on the ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... AUSTIN, Texas , March 27, 2017   Genprex, Inc. ... announced that Julien Pham , MD, the Company,s Chief Operating ... healthcare investor conferences. Sachs 5th Annual Cancer BioPartnering ... in New York, NY ... BioCentury 24th Annual Future Leaders ...
Breaking Medicine Technology: